Thermo Fisher Scientific Inc. (NYSE:TMO) – Equities researchers at Leerink Swann lifted their Q1 2017 earnings per share estimates for shares of Thermo Fisher Scientific in a research report issued to clients and investors on Friday. Leerink Swann analyst P. Souda now anticipates that the firm will post earnings of $2.20 per share for the quarter, up from their prior estimate of $2.19. Leerink Swann has a “Buy” rating and a $175.00 price objective on the stock. Leerink Swann also issued estimates for Thermo Fisher Scientific’s Q2 2017 earnings at $2.34 EPS, Q3 2017 earnings at $2.33 EPS, Q4 2017 earnings at $2.49 EPS, FY2017 earnings at $9.36 EPS, Q1 2018 earnings at $2.44 EPS, Q2 2018 earnings at $2.60 EPS, Q3 2018 earnings at $2.60 EPS, FY2018 earnings at $10.40 EPS and FY2019 earnings at $11.78 EPS.

Several other analysts also recently weighed in on TMO. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $172.00 price objective for the company in a research report on Thursday, October 13th. Bank of America Corp. set a $180.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Friday, October 7th. JPMorgan Chase & Co. initiated coverage on shares of Thermo Fisher Scientific in a research report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 price objective for the company. Cleveland Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research report on Friday, September 9th. Finally, Jefferies Group restated a “hold” rating on shares of Thermo Fisher Scientific in a research report on Thursday, August 4th. Two analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $164.37.

Earnings History and Estimates for Thermo Fisher Scientific (NYSE:TMO)

Shares of Thermo Fisher Scientific (NYSE:TMO) opened at 146.17 on Monday. The stock has a market cap of $57.74 billion, a PE ratio of 29.22 and a beta of 1.24. The firm has a 50-day moving average of $151.27 and a 200 day moving average of $152.05. Thermo Fisher Scientific has a 52 week low of $119.75 and a 52 week high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.97 by $0.06. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The company had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.39 billion. During the same quarter in the previous year, the company earned $1.80 EPS. Thermo Fisher Scientific’s revenue for the quarter was up 8.9% on a year-over-year basis.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 16th. Stockholders of record on Thursday, December 15th will be paid a dividend of $0.15 per share. The ex-dividend date is Tuesday, December 13th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.41%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 12.00%.

In related news, CEO Marc N. Casper sold 30,000 shares of the stock in a transaction dated Thursday, September 1st. The shares were sold at an average price of $151.17, for a total value of $4,535,100.00. Following the sale, the chief executive officer now directly owns 308,647 shares of the company’s stock, valued at approximately $46,658,166.99. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Marc N. Casper sold 28,797 shares of the stock in a transaction dated Friday, September 2nd. The shares were sold at an average price of $151.01, for a total transaction of $4,348,634.97. Following the completion of the sale, the chief executive officer now directly owns 307,444 shares in the company, valued at $46,427,118.44. The disclosure for this sale can be found here. Insiders own 0.52% of the company’s stock.

A number of large investors have recently modified their holdings of TMO. Moors & Cabot Inc. boosted its stake in shares of Thermo Fisher Scientific by 0.4% in the second quarter. Moors & Cabot Inc. now owns 1,994 shares of the company’s stock worth $294,000 after buying an additional 7 shares during the last quarter. Brown Advisory Securities LLC boosted its stake in shares of Thermo Fisher Scientific by 0.4% in the second quarter. Brown Advisory Securities LLC now owns 2,388 shares of the company’s stock worth $353,000 after buying an additional 10 shares during the last quarter. Mycio Wealth Partners LLC boosted its stake in shares of Thermo Fisher Scientific by 1.6% in the second quarter. Mycio Wealth Partners LLC now owns 711 shares of the company’s stock worth $105,000 after buying an additional 11 shares during the last quarter. Parsec Financial Management Inc. boosted its stake in shares of Thermo Fisher Scientific by 0.6% in the third quarter. Parsec Financial Management Inc. now owns 1,938 shares of the company’s stock worth $308,000 after buying an additional 12 shares during the last quarter. Finally, Choate Investment Advisors boosted its stake in shares of Thermo Fisher Scientific by 0.4% in the third quarter. Choate Investment Advisors now owns 3,358 shares of the company’s stock worth $534,000 after buying an additional 15 shares during the last quarter. 87.45% of the stock is currently owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.